You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 134 No. 9, September 1998 TABLE OF CONTENTS
  Archives
  •  Online Features
  Observation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (111)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Dermatology
 •Dermatologic Disorders
 •Herpes
 •Genetics
 •Genetic Counseling/ Testing/ Therapy
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Human Herpesvirus 6 Infection as a Risk Factor for the Development of Severe Drug-Induced Hypersensitivity Syndrome

Yosuke Suzuki, MD; Reiko Inagi, PhD; Toshiya Aono, MSc; Koichi Yamanishi, MD; Tetsuo Shiohara, MD

Arch Dermatol. 1998;134:1108-1112.

Background  Drug-induced hypersensitivity syndrome is characterized by a severe, potentially fatal, multiorgan hypersensitivity reaction that usually appears after prolonged exposure to certain drugs. Its delayed onset and clinical resemblance to infectious mononucleosis suggest that underlying viral infections may trigger and activate the disease in susceptible individuals receiving these drugs.

Observations  A 60-year-old woman developed an itchy, generalized, erythematous, confluent rash on the 39th day of receiving allopurinol therapy. Even after she discontinued treatment with allopurinol, her skin lesions progressed to a severe blistering skin eruption. After the patient started oral prednisone therapy, her skin lesions resolved with desquamation. After complete resolution, rechallenge with allopurinol led to the development of an erythematous eruption. Titers of human herpesvirus 6 IgG antibodies dramatically increased with the development of the eruption. The results of a polymerase chain reaction and in situ hybridization indicated the presence of human herpesvirus 6 in the skin lesions, although human herpesvirus 7 DNA was detected only by in situ hybridization.

Conclusion  Reactivation of human herpesvirus 6, possibly in concert with human herpesvirus 7, can contribute to the development of a severe drug-induced hypersensitivity syndrome.


From the Department of Dermatology, Kyorin University School of Medicine, Tokyo (Drs Suzuki and Shiohara), and the Department of Microbiology, Osaka University Medical School, Osaka (Drs Inagi and Yamanishi and Mr Aono), Japan.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Human Herpesviruses 6 and 7: New Roles Yet to Be Discovered?
Laurence Le Cleach, Anne Marie Fillet, Henri Agut, and Olivier Chosidow
Arch Dermatol. 1998;134(9):1155-1157.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A case of sulphasalazine-induced DRESS syndrome with delayed acute interstitial nephritis
Augusto et al.
Nephrol Dial Transplant 2009;24:2940-2942.
ABSTRACT | FULL TEXT  

Cytomegalovirus Disease During Severe Drug Eruptions: Report of 2 Cases and Retrospective Study of 18 Patients With Drug-Induced Hypersensitivity Syndrome
Asano et al.
Arch Dermatol 2009;145:1030-1036.
ABSTRACT | FULL TEXT  

Defective Regulatory T Cells In Patients with Severe Drug Eruptions: Timing of the Dysfunction Is Associated with the Pathological Phenotype and Outcome
Takahashi et al.
J. Immunol. 2009;182:8071-8079.
ABSTRACT | FULL TEXT  

Viruses may trigger allopurinol hypersensitivity syndrome
Koike et al.
NDT Plus 2008;1:273-274.
FULL TEXT  

Toxic Epidermal Necrolysis Due to Zonisamide Associated With Reactivation of Human Herpesvirus 6
Teraki et al.
Arch Dermatol 2008;144:232-235.
ABSTRACT | FULL TEXT  

HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol
Hung et al.
Proc. Natl. Acad. Sci. USA 2005;102:4134-4139.
ABSTRACT | FULL TEXT  

Codeine Phosphate-Induced Hypersensitivity Syndrome
Enomoto et al.
The Annals of Pharmacotherapy 2004;38:799-802.
ABSTRACT | FULL TEXT  

Association Between Anticonvulsant Hypersensitivity Syndrome and Human Herpesvirus 6 Reactivation and Hypogammaglobulinemia
Kano et al.
Arch Dermatol 2004;140:183-188.
ABSTRACT | FULL TEXT  

Is a Drug Alone Sufficient to Cause the Drug Hypersensitivity Syndrome?
Wong and Shear
Arch Dermatol 2004;140:226-230.
FULL TEXT  

Delayed Drug Hypersensitivity Reactions
Pichler
ANN INTERN MED 2003;139:683-693.
ABSTRACT | FULL TEXT  

Human herpesvirus 6: molecular biology and clinical features
Dockrell
J Med Microbiol 2003;52:5-18.
ABSTRACT | FULL TEXT  

Neutralizing Antibody Responses to Human Herpesviruses 6 and 7 Do Not Cross-React with Each Other, and Maternal Neutralizing Antibodies Contribute to Sequential Infection with These Viruses in Childhood
Yoshida et al.
CVI 2002;9:388-393.
ABSTRACT | FULL TEXT  

Drug Hypersensitivity Syndrome and Human Herpesvirus 6 Reactivation
Tohyama et al.
Arch Dermatol 2002;138:268-269.
FULL TEXT  

Drug-Induced Hypersensitivity Syndrome in Pediatric Patients
Carroll et al.
Pediatrics 2001;108:485-492.
ABSTRACT | FULL TEXT  

Rapid Loss of Insulin Secretion in a Patient With Fulminant Type 1 Diabetes Mellitus and Carbamazepine Hypersensitivity Syndrome
Sekine et al.
JAMA 2001;285:1153-1154.
FULL TEXT  

Association of Human Herpesvirus 6 Infection With Drug Reaction With Eosinophilia and Systemic Symptoms
Descamps et al.
Arch Dermatol 2001;137:301-304.
ABSTRACT | FULL TEXT  

Human Herpesviruses 6 and 7: New Roles Yet to Be Discovered?
Le Cleach et al.
Arch Dermatol 1998;134:1155-1157.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.